Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Cabozantinib
Related studies linked through entity extraction aliases.
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Drug Rediscovery Protocol (DRUP Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer
- Status
- COMPLETED
- Phase
- NA
A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Ph II CABOGIST in GIST
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting
- Status
- UNKNOWN
- Phase
- PHASE2
Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC
- Status
- TERMINATED
- Phase
- PHASE2
IRCI Gynae Sarcomas, High Grade Uterine Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1